Daplusiran/Tomligisiran (DAP/TOM)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Daplusiran/Tomligisiran (DAP/TOM), covering 2025-07-28 to 2025-07-28. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB) [Phase 2]